Pralatrexate + Romidepsin in Relapsed/Refractory Lymphoid Malignancies
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Clinical Trials Related to Hodgkin Lymphoma
Related studies linked through entity extraction aliases.
Safety Study of CPX-351 in Children With Relapsed Leukemia or Lymphoma
- Status
- COMPLETED
- Phase
- PHASE1
Phase 1 Study of CC-486 in Japanese Subjects With Hematological Neoplasms
- Status
- TERMINATED
- Phase
- PHASE1
Bendamustine Hydrochloride, Clofarabine, and Etoposide in Treating Younger Patients With Relapsed or Refractory Hematologic Malignancies
- Status
- COMPLETED
- Phase
- PHASE1
Brentuximab Vedotin Combined With AVD Chemotherapy in Patients With Newly Diagnosed Early Stage, Unfavorable Risk Hodgkin Lymphoma
- Status
- COMPLETED
- Phase
- NA
Brain Integrity in Survivors of Hodgkin Lymphoma Treated With Thoracic Radiation
- Status
- COMPLETED
- Phase
- N/A
Blood Sample Markers of Reproductive Hormones in Assessing Ovarian Reserve in Younger Patients With Newly Diagnosed Lymphomas
- Status
- COMPLETED
- Phase
- N/A
Unrelated Umbilical Cord Blood (UBC)Transplantation
- Status
- COMPLETED
- Phase
- NA
Prevention of Ovarian Function Damage by a GnRH Analogue During Chemotherapy in Hodgkin Lymphoma Patients
- Status
- COMPLETED
- Phase
- NA
Reduced-Intensity Conditioning Before Donor Stem Cell Transplant in With High-Risk Hematologic Malignancies
- Status
- COMPLETED
- Phase
- PHASE2
A Frontline Therapy Trial in Participants With Advanced Classical Hodgkin Lymphoma
- Status
- COMPLETED
- Phase
- PHASE3
BMS_PD-L1_onco : Assessment of the PD-L1 Protein as a Biomarker in Oncology and Hematology
- Status
- COMPLETED
- Phase
- N/A
Brentuximab Vedotin and Bendamustine for the Treatment of Hodgkin Lymphoma and Anaplastic Large Cell Lymphoma (ALCL)
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Very Early FDG-PET/CT-response Adapted Therapy for Advanced Hodgkin Lymphoma (H11)
- Status
- WITHDRAWN
- Phase
- PHASE3
Inducible Regulatory T Cells (iTregs) in Non-Myeloablative Sibling Donor Peripheral Blood Stem Cell Transplantation
- Status
- COMPLETED
- Phase
- PHASE1
Donor-Derived Humoral Immunity, Hematopoietic Stem Cell Transplantation, TAR
- Status
- COMPLETED
- Phase
- NA
Double Cord Versus Haploidentical (BMT CTN 1101)
- Status
- COMPLETED
- Phase
- PHASE3
An Investigational Immuno-Therapy Study to Determine the Safety and Effectiveness of Nivolumab and Daratumumab in Patients With Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Study of Lymphoma in Asia
- Status
- COMPLETED
- Phase
- N/A
Targeted BEACOPP Variants in Patients With Newly Diagnosed Advanced Classical Hodgkin Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2